RASP and Immune Mediated Disease Interview with John Sheppard, MD, MMsc, President of Virginia Eye Consultants. Join us as we dive into the deep with Dr. Sheppard on the topic of inflammatory dry eye.  The future of anti-inflammatory dry eye therapy is more than the T-Cell response. Dr. Sheppard gives us his perspectives on RASP (reactive aldehyde species) inhibitors, and Acthar (corticotropin) injections as potential dry eye therapies of the future.

Interview with Peter Sallstig, MD, MBA

Santen’s legacy, global products, NA product portfolio, clinical trials and more.Peter also dives into the disease state of vernal keratoconjunctivitis (VKC) and the recent US launch of Verkazia®, the first and only topical immunomodulator approved for the treatment of VKC in children and adults

Interview with Dr. Josh Johnston of Georgia Eye Partners. Dr. Johnston shares with us his tips and tricks for successful Meibomian Gland Dysfunction (MGD) Treatment.  We also highlight some exciting new therapies coming down the pipeline that have the potential to cause big changes in MGD treatment in the near future.

Interview with Lisa Hornick, OD, FAAO, from Stanford Ranch Optometry.  Optometry Diva’s Dr. Lisa Hornick brings us her fresh clinical perspective on helpful dry eye therapies utilizing improved drug delivery systems, as well as discussing her tips for dry eye treatment success.

Interview with Laura Periman, MD from Periman Eye Institute.

The Dry Eye Master graces us with her deep knowledge of how to maximize the body’s nervous system to assist with successful dry eye therapy. She discusses the ideal patient type, dosing, and tips to maximize patient outcomes.  This is an episode you can’t miss!

Interview with Mila Ioussifova, OD, FAAO

Thanks to the “Zoom Boom,” patients are aware of personal appearance now, more aware than ever before.  In this episode, Dr. Mila Ioussifova discusses latest modern options for both health and aesthetics to give patients the lift they need!

Want to hear what is new and exciting in the dry eye space? Listen in on thoughts, tips, tricks and pearls from Dr. Damon Dierker, Founder of Dry Eye Boot Camp and Co-Chair of Eyes on Dry Eye, on his thoughts on current and future innovations in ocular surface disease.

Novel Dry Eye Treatment Pathways: Understanding the MOA

With so many pharmaceutical treatment options, how do you decide which treatment to prescribe? From dry eye flares to chronic dry eye therapies, Dr. Doug Devries will provide his insights on how the mechanism of action (MOA) for our current and newest dry eye treatment options impacts his decision making and management.

Interview with Selina McGee, OD, FAAO, Dipl ABO- BeSpoke Vision.  With so many “letter options” available for patient care, it can be difficult to navigate the differences between the latest treatments for ocular surface dryness.  In this episode, Dr. Selina McGee spells-out exactly how these new treatments can help patients get dry eye relief.

Interview with Derek Cunningham, OD

Steroids plays an integral role in the treatment of dry eye disease for acute and chronic inflammation.  Although steroids have been used off-label for many years to address inflammation, the question remains is does on-label or off-label indication matter?  In this episode, Derek Cunningham, OD, FAAO shares his thought on the subject and how he utilizes steroids in clinical practice.